IGNHLIntermediate Grade Non-Hodgkin's Lymphoma
References in periodicals archive ?
To be eligible for inclusion in the study, a patient should have been treated for IGNHL (stages I to IV), be at least 18 years of age, and have received only one chemotherapy regimen within 3 years of the studied chemotherapy course.
The study data were extracted from the medical records of patients with IGNHL.
The purpose of this retrospective study was to determine at baseline (time of cancer diagnosis before chemotherapy) the prevalence, risk factors, and prognostic value of anemia in a group of patients with IGNHL treated in community-based practice.
In contrast, our study included only patients with IGNHL treated with CHOP, and response to chemo therapy was documented from the chart and follow-up.